ACS chemical neuroscience

PloS one

Chemistry (Weinheim an der Bergstrasse, Germany)

conference proceedings : annual international conference of the ieee engineering in medicine and biology society ieee engineering in medicine and biology society annual conference

Journal of Alzheimer's disease : JAD

Stroke

journal of neurosurgery

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

ejnmmi research

japanese journal of radiology

ieee transactions on radiation and plasma medical sciences

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

Diagnostics (Basel, Switzerland)

journal of neuropathology and experimental neurology

the oncologist

European journal of neurology

methods (san diego, calif)

cortex; a journal devoted to the study of the nervous system and behavior

the european physical journal c, particles and fields

Radiographics : a review publication of the Radiological Society of North America, Inc

personality disorders

journal of cerebral blood flow and metabolism : official journal of the international society of cerebral blood flow and metabolism

bmc medical imaging

The journal of prevention of Alzheimer's disease

cardiology in review

nature reviews nephrology

[1] Phospholipids are A Potentially Important Source of Tissue Biomarkers for Hepatocellular Carcinoma: Results of a Pilot Study Involving Targeted Metabolomics.

[2] The impact of iterative reconstruction protocol, signal-to-background ratio and background activity on measurement of PET spatial resolution.

[3] Plastic Scintillator-Based Microfluidic Devices for Miniaturized Detection of Positron Emission Tomography Radiopharmaceuticals.

[4] Jet energy measurement and its systematic uncertainty in proton-proton collisions at [Formula: see text] TeV with the ATLAS detector.

[5] Two-particle Bose-Einstein correlations in collisions at [Formula: see text] 0.9 and 7 TeV measured with the ATLAS detector.

[6] Measurement of three-jet production cross-sections in [Formula: see text] collisions at 7 [Formula: see text] centre-of-mass energy using the ATLAS detector.

[7] A Risk Score Including Carotid Plaque Inflammation and Stenosis Severity Improves Identification of Recurrent Stroke.

[8] Single-trial Connectivity Estimation through the Least Absolute Shrinkage and Selection Operator.

[9] The effects of different tracking tasks on muscle synergy through visual feedback.

[10] The development and validation of a measurement instrument to investigate determinants of health care utilisation for low back pain in Ethiopia.

[11] Comparing the interpersonal profiles of obsessive-compulsive personality disorder and avoidant personality disorder: Are there homogeneous profiles or interpersonal subtypes?

[12] Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.

[13] PET Image Reconstruction Using Physical and Mathematical Modelling For Time of Flight PET-MR Scanners in the STIR Library.

[14] Comprehensive Assessment of Endomyocardial Fibrosis with Cardiac MRI: Morphology, Function, and Tissue Characterization.

[15] A strategy to account for noise in the X-variable to reduce underestimation in Logan graphical analysis for quantifying receptor density in positron emission tomography.

[16] Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools.

[17] Guidelines for the content and format of PET brain data in publications and archives: A consensus paper.

[18] Association of metabolic and genetic heterogeneity in head and neck squamous cell carcinoma with prognostic implications: integration of FDG PET and genomic analysis.

[19] Machine learning in quantitative PET: A review of attenuation correction and low-count image reconstruction methods.

[20] The current and future landscape of dialysis.

[21] ASSESSMENT OF THE PATIENT WITH INTRACEREBRAL HEMORRHAGE: A REVIEW OF THE LITERATURE.

[22] Association of Regional Bone Synthetic Activities of Vertebral Corners and Vertebral Bodies Quantified Using 18F-Fluoride Positron Emission Tomography with Bone Mineral Density on Dual Energy X-ray Absorptiometry in Patients with Ankylosing Spondylitis

[23] siderophore-based molecular imaging of fungal and bacterial infections—current status and future perspectives

[24] huge liver tumor in young man

[25] syntheses of precursors and reference compounds of the melanin-concentrating hormone receptor 1 (mchr1) tracers [11c]snap-7941 and [18f]fe@snap for positron emission tomography

[26] imaging in tuberculosis

[27] the influence of the combination of carboxylate and phosphinate pendant arms in 1,4,7-triazacyclononane-based chelators on their 68ga labelling properties

[28] gabaa receptor availability changes underlie symptoms in isolated cervical dystonia

[29] design and prototype of an automated column-switching hplc system for radiometabolite analysis

[30] positron emission tomography imaging of tumor cell metabolism and application to therapy response monitoring

[31] diagnostic and prognostic significance of methionine uptake and methionine positron emission tomography imaging in gliomas

[32] influence of the scintillation crystal option on the detector response of pet devices

[33] 68ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: current state and future trends

[34] radioiodination of aryl-alkyl cyclic sulfates

[35] clinical utility of positron emission tomography magnetic resonance imaging (pet-mri) in gastrointestinal cancers

[36] Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer’s disease differ according to disease severity and amyloid positivity

[37] Combined analog/digital approach to performance optimization for the LAPET whole-body TOF PET scanner

[38] Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic

[39] The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer’s diseases— A simulation study combining multi-center data and ADNI-data

[40] Activated Microglia in the Early Stage of a Rat Model of Parkinson's Disease: Revealed by PET-MRI Imaging by [F]DPA-714 Targeting TSPO.

[41] Optic Tract Involvement in a Patient With Relapsing Polychondritis.

[42] Difference in trajectories according to early amyloid accumulation in cognitively unimpaired elderly.

[43] Convergent Multimodal Imaging Abnormalities in the Dorsal Precuneus in Subjective Cognitive Decline.

[44] Longitudinal Trajectories of the Cognitive Function Index in the A4 Study.

[45] Fluorine-18 Labeling of S100 Proteins for Small Animal Positron Emission Tomography.

[46] Asymmetric Synthesis of Spirocyclic 2-Benzopyrans for Positron Emission Tomography of σ1 Receptors in the Brain.

[47] An Incidental Solitary Plasmacytoma of Bone Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography.

[48] Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system.

[49] Identification of brain regions predicting epileptogenesis by serial [18F]GE-180 positron emission tomography imaging of neuroinflammation in a rat model of temporal lobe epilepsy

[50] Brain network alterations in individuals with and without mild cognitive impairment: Parallel independent component analysis of AV1451 and AV45 positron emission tomography

[51] Positron emission tomography imaging of endogenous mu-opioid mechanisms during pain and migraine.

[52] Synchronous Pancreatic Solid Pseudopapillary Neoplasm Masquerading as Extralymphatic Involvement on F-Fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computed Tomography in a Case of Hodgkin's Lymphoma.

[53] A Case of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging of Eosinophilic Granulomatosis With Polyangiitis Combined With Non-tuberculous Mycobacterium.

[54] Plastic Scintillator-Based Microfluidic Devices for Miniaturized Detection of Positron Emission Tomography Radiopharmaceuticals.

[55] Striatal dopamine D2 binding correlates with locus of control: Preliminary evidence from [C]raclopride Positron Emission Tomography.

[56] New approach in radiometabolite analysis of positron emission tomography (PET) radioligands; lead-shielded microextraction by packed sorbent as a tool for in vivo radiometabolite analysis of [C]SMW139 in rat plasma.

[57] ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography features in locally advanced breast cancer and their correlation with molecular subtypes

[58] Neural substrate of a cognitive intervention program using Go game: a positron emission tomography study.

[59] A strategy to account for noise in the X-variable to reduce underestimation in Logan graphical analysis for quantifying receptor density in positron emission tomography.

[60] The use of brain positron emission tomography to identify sites of postoperative pain processing with and without epidural analgesia

[61] Paclitaxel-induced dermal hypersensitivity lesions: 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography.

[62] Positron emission tomography/computed tomography dual imaging using 18-fluorine flurodeoxyglucose and 11C-labeled 2-β-carbomethoxy-3-β-(4-fluorophenyl) tropane for the severity assessment of Parkinson disease.

[63] Positron emission tomography of tau in Iraq and Afghanistan Veterans with blast neurotrauma

[64] Association of Regional Bone Synthetic Activities of Vertebral Corners and Vertebral Bodies Quantified Using 18F-Fluoride Positron Emission Tomography with Bone Mineral Density on Dual Energy X-ray Absorptiometry in Patients with Ankylosing Spondylitis

[65] INSIDE in-beam positron emission tomography system for particle range monitoring in hadrontherapy

[66] positron emission tomography—computer tomography scan used as a monitoring tool following cellular therapy in cerebral palsy and mental retardation—a case report

[67] syntheses of precursors and reference compounds of the melanin-concentrating hormone receptor 1 (mchr1) tracers [11c]snap-7941 and [18f]fe@snap for positron emission tomography

[68] evaluation of partial volume effect correction methods for brain positron emission tomography: quantification and reproducibility

[69] the role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: an overview

[70] are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lung carcinoma? a retrospective fluorodeoxyglucose positron emission tomography/computed tomography study

[71] positron emission tomography imaging of tumor cell metabolism and application to therapy response monitoring

[72] features of endobronchial metastases from extrathoracic malignancy and positron emission tomography-computerized tomography findings

[73] 18-fluoro-2-deoxyglucose positron emission tomography–computed tomography: an additional tool in the diagnosis of prosthetic valve endocarditis

[74] current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo

[75] surgical management of a coronary-bronchial artery fistula combined with myocardial ischemia revealed by 13n-ammonia positron emission tomography

[76] role of fluorodeoxyglucose positron emission tomography-computed tomography in thyroid malignancy

[77] diagnostic and prognostic significance of methionine uptake and methionine positron emission tomography imaging in gliomas

[78] assessment of cancer-associated biomarkers by positron emission tomography: advances and challenges

[79] 68ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: current state and future trends

[80] impact and prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography scan in the evaluation of residual head and neck cancer: single-center experience from pakistan

[81] positron emission tomography reveals abnormal topological organization in functional brain network in diabetic patients

[82] sex differences of brain serotonin synthesis in patients with irritable bowel syndrome using α-[11c]methyl-l-tryptophan, positron emission tomography and statistical parametric mapping

[83] positron emission tomography in breast cancer

[84] clinical utility of positron emission tomography magnetic resonance imaging (pet-mri) in gastrointestinal cancers

[85] The image quality, amyloid-β detectability, and acquisition time of clinical florbetapir positron emission tomography in Alzheimer’s disease and healthy adults

[86] Dual-phase ¹⁸F-florbetapir positron emission tomography in patients with primary progressive aphasia, Alzheimer's disease, and healthy controls: A preliminary study

[87] Clinical and cost implications of amyloid beta detection with amyloid beta positron emission tomography imaging in early Alzheimer’s disease–the case of florbetapir

[88] Diagnosis of Alzheimer disease: Advances and benefits of florbetapir positron emission tomography (PET) and other amyloid radioligands